Foundation Wealth Management (Pennsylvania)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$719K Sell
5,596
-131
-2% -$15.3K 0.22% 51
2026
Q1
$689K Sell
5,727
-12
-0.2% -$1.39K 0.24% 46
2025
Q4
$604K Hold
5,739
0.22% 52
2025
Q3
$482K Sell
5,739
-15
-0.3% -$1.24K 0.19% 62
2025
Q2
$455K Buy
5,754
+393
+7% +$31.2K 0.2% 64
2025
Q1
$481K Buy
5,361
+127
+2% +$11.9K 0.23% 55
2024
Q4
$521K Buy
+5,234
New +$540K 0.25% 51

Other funds holding MRK

Foundation Wealth Management (Pennsylvania)'s MRK Position: Q2 2026 in Review

Foundation Wealth Management (Pennsylvania) reduced its Merck (MRK) stake by 2.3% in Q2 2026, selling an estimated $15.3K and leaving 5,596 shares worth $719K. The position accounts for 0.22% of the portfolio, ranked #51.

Foundation Wealth Management (Pennsylvania) first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Foundation Wealth Management (Pennsylvania) held 5,596 shares of Merck worth $719K as of Q2 2026.
  • Foundation Wealth Management (Pennsylvania) sold 131 Merck shares in Q2 2026, an estimated $15.3K.
  • Merck made up 0.22% of Foundation Wealth Management (Pennsylvania)'s portfolio in Q2 2026, its #51 holding.
  • Foundation Wealth Management (Pennsylvania) first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Foundation Wealth Management (Pennsylvania)'s 13F filing for Q2 2026, filed 22 Jul 2026.